Authors:
Hoedemaeker, RF
van der Kwast, TH
Boer, R
de Koning, HJ
Roobol, M
Vis, AN
Schroder, FH
Citation: Rf. Hoedemaeker et al., Pathologic features of prostate cancer found at population-based screeningwith a four-year interval, J NAT CANC, 93(15), 2001, pp. 1153-1158
Authors:
Bindels, EMJ
Vermey, M
De Both, NJ
van der Kwast, TH
Citation: Emj. Bindels et al., Influence of the microenvironment on invasiveness of human bladder carcinoma cell lines, VIRCHOWS AR, 439(4), 2001, pp. 552-559
Authors:
van der Flier, S
van der Kwast, TH
Claassen, CJC
Timmermans, M
Brinkman, A
Henzen-Logmans, SC
Foekens, JA
Dorssers, LCJ
Citation: S. Van Der Flier et al., Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue, INT J B MAR, 16(3), 2001, pp. 172-178
Authors:
Altun, V
Hakvoort, TE
van Zuijlen, PPM
van der Kwast, TH
Prens, EP
Citation: V. Altun et al., Nerve outgrowth and neuropeptide expression during the remodeling of humanburn wound scars - A 7-month follow-up study of 22 patients, BURNS, 27(7), 2001, pp. 717-722
Authors:
Vis, AN
Hoedemaeker, RF
Roobol, M
van der Kwast, TH
Schroder, FH
Citation: An. Vis et al., Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml), PROSTATE, 47(4), 2001, pp. 252-261
Authors:
Vis, AN
Hoedemaeker, RF
van der Kwast, TH
Schroder, FH
Citation: An. Vis et al., Defining the window of opportunity in screening for prostate cancer: Validation of a predictive tumor classification model, PROSTATE, 46(2), 2001, pp. 154-162
Authors:
Jimenez, N
Jongsma, J
Calvo, A
van der Kwast, TH
Treston, AM
Cuttitta, F
Schroder, FH
Montuenga, LM
van Steenbrugge, GJ
Citation: N. Jimenez et al., Peptidylglycine alpha-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate, INT J CANC, 94(1), 2001, pp. 28-34
Authors:
van Rhijn, BWG
Lurkin, I
Radvanyi, F
Kirkels, WJ
van der Kwast, TH
Zwarthoff, EC
Citation: Bwg. Van Rhijn et al., The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate, CANCER RES, 61(4), 2001, pp. 1265-1268
Authors:
Foekens, JA
Peters, HA
Grebenchtchikov, N
Look, MP
Meijer-van Gelder, ME
Geurts-Moespot, A
van der Kwast, TH
Sweep, CGJ
Klijn, JGM
Citation: Ja. Foekens et al., High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer, CANCER RES, 61(14), 2001, pp. 5407-5414
Authors:
van Rhijn, BWG
Lurkin, I
Kirkels, WJ
van der Kwast, TH
Zwarthoff, EC
Citation: Bwg. Van Rhijn et al., Microsatellite analysis - DNA test in urine competes with cystoscopy in follow-up of superficial ladder carcinoma - A phase II trial, CANCER, 92(4), 2001, pp. 768-775
Authors:
Vis, AN
Hoedemaeker, RF
Roobol, M
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma - An evaluation from a randomized, population-basedstudy of screening for prostate cancer, CANCER, 92(3), 2001, pp. 524-534
Authors:
Alers, JC
Krijtenburg, PJ
Vis, AN
Hoedemaeker, RF
Wildhagen, MF
Hop, WCJ
van der Kwast, TH
Schroder, FH
Tanke, HJ
van Dekken, H
Citation: Jc. Alers et al., Molecular cytogenetic analysis of prostatic adenocarcinomas from screeningstudies - Early cancers may contain aggressive genetic features, AM J PATH, 158(2), 2001, pp. 399-406
Authors:
Vis, AN
Kranse, R
Nigg, AL
van der Kwast, TH
Citation: An. Vis et al., Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections, AM J CLIN P, 113(3), 2000, pp. 369-373
Authors:
Jongsma, J
Oomen, MHA
Noordzij, MA
Romijn, JC
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines, PROSTATE, 42(1), 2000, pp. 34-44
Authors:
Vis, AN
Boerma, MO
Ciatto, S
Hoedemaeker, RF
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., Detection of prostate cancer: A comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy, UROLOGY, 56(4), 2000, pp. 617-621
Authors:
Verkaik, NS
van Steenbrugge, GJ
van Weerden, WM
Bussemakers, MJ
van der Kwast, TH
Citation: Ns. Verkaik et al., Silencing of CD44 expression in prostate cancer by hypermethylation of theCD44 promoter region, LAB INV, 80(8), 2000, pp. 1291-1298
Authors:
Vis, AN
Noordzij, MA
Fitoz, K
Wildhagen, MF
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer, J UROL, 164(6), 2000, pp. 2156-2161
Authors:
Hoedemaeker, RF
Rietbergen, JBW
Kranse, R
Schroder, FH
van der Kwast, TH
Citation: Rf. Hoedemaeker et al., Histopathological prostate cancer characteristics at radical prostatectomyafter population based screening, J UROL, 164(2), 2000, pp. 411-415
Authors:
Jongsma, J
Oomen, MH
Noordzij, MA
Van Weerden, WM
Martens, GJM
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen deprivation of the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiation, CANCER RES, 60(3), 2000, pp. 741-748
Authors:
van Schaik, RHN
Wierikx, CDJ
Timmerman, MA
Oomen, MH
van Weerden, WM
van der Kwast, TH
van Steenbrugge, GJ
de Jong, FH
Citation: Rhn. Van Schaik et al., Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues, BR J CANC, 82(1), 2000, pp. 112-117
Authors:
Alexander, FE
Andriole, GL
Aus, G
Auvinen, A
Beensterboer, P
Blijenberg, BG
Bonardi, R
Buys, S
Candas, B
Ciatto, S
Crawford, ED
Demers, R
de Koning, HJ
Denis, L
Dijk, MA
Figueiredo, F
Gellman, EP
Gohagan, J
Hakama, M
Hugosson, J
Kirkels, WI
Kranse, R
van der Kwast, TH
Lilja, H
Maattanen, L
Mandel, J
Miller, AB
Monteiro, H
Nelen, V
Oberman, A
Paez, A
Prorok, PC
Reding, D
Rietbergen, JWBW
Rose, DB
Sanchez, AB
Schroder, FH
da Silva, EC
Simpson, N
Smith, PH
Stadaert, B
Stenman, UH
Teppo, L
Turkes, A
Weissfeld, JL
Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271